Gland Pharma Ltd
NSE:GLAND
Intrinsic Value
Gland Pharma Ltd. manufactures pharmaceutical ingredients and injectable formulations. [ Read More ]
The intrinsic value of one GLAND stock under the Base Case scenario is 1 403.61 INR. Compared to the current market price of 1 710 INR, Gland Pharma Ltd is Overvalued by 18%.
Valuation Backtest
Gland Pharma Ltd
Run backtest to discover the historical profit from buying and selling GLAND stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Gland Pharma Ltd
Current Assets | 59.7B |
Cash & Short-Term Investments | 21.4B |
Receivables | 14.6B |
Other Current Assets | 23.6B |
Non-Current Assets | 43.2B |
Long-Term Investments | 1.2B |
PP&E | 34.1B |
Intangibles | 6.1B |
Other Non-Current Assets | 1.8B |
Current Liabilities | 15.4B |
Accounts Payable | 9.8B |
Other Current Liabilities | 5.6B |
Non-Current Liabilities | 4.5B |
Long-Term Debt | 1.5B |
Other Non-Current Liabilities | 3B |
Earnings Waterfall
Gland Pharma Ltd
Revenue
|
49.1B
INR
|
Cost of Revenue
|
-19.4B
INR
|
Gross Profit
|
29.7B
INR
|
Operating Expenses
|
-21.2B
INR
|
Operating Income
|
8.5B
INR
|
Other Expenses
|
-1.9B
INR
|
Net Income
|
6.6B
INR
|
Free Cash Flow Analysis
Gland Pharma Ltd
GLAND Profitability Score
Profitability Due Diligence
Gland Pharma Ltd's profitability score is 60/100. The higher the profitability score, the more profitable the company is.
Score
Gland Pharma Ltd's profitability score is 60/100. The higher the profitability score, the more profitable the company is.
GLAND Solvency Score
Solvency Due Diligence
Gland Pharma Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Score
Gland Pharma Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
GLAND Price Targets Summary
Gland Pharma Ltd
According to Wall Street analysts, the average 1-year price target for GLAND is 1 844.36 INR with a low forecast of 1 141.3 INR and a high forecast of 3 276 INR.
Shareholder Return
GLAND Price
Gland Pharma Ltd
Average Annual Return | 11.23% |
Standard Deviation of Annual Returns | 62.99% |
Max Drawdown | -79% |
Market Capitalization | 281.6B INR |
Shares Outstanding | 164 700 800 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Gland Pharma Ltd. manufactures pharmaceutical ingredients and injectable formulations. The company is headquartered in Hyderabad, Telangana. The company went IPO on 2020-11-20. The firm provides a range of injectables including vials, ampoules, pre-filled syringes, lyophilized vials, dry powders, infusions and ophthalmic solutions. The company provides contract development and manufacturing services, such as evaluation of development needs, identifying application program interface (API) sources, analytical method development, formulation development and product/technology know-how; and manufacturing of registration batches, studies, dossier compilation for regulatory submission and commercial production. The Company’s therapeutic products categories include Anti Malarials, Anti-Infectives, Anti-Neoplastics, Blood Related, Cardiac, Gastrointestinal, Gynaecological, Hormones, Neuro / Cns Ophthal / Otologicals, Pain/Analgesics, Respiratory and Vitamins / Minerals / Nutrients.
Contact
IPO
Employees
Officers
The intrinsic value of one GLAND stock under the Base Case scenario is 1 403.61 INR.
Compared to the current market price of 1 710 INR, Gland Pharma Ltd is Overvalued by 18%.